Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Epigenetics and DNA Methylation, Cancer Genomics and Diagnostics, Cancer Cells and Metastasis, and Estrogen and related hormone effects.
Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer
Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
Targeted nanopore sequencing with Cas9-guided adapter ligation
Nanoparticle interactions with immune cells dominate tumor retention and induce T cell–mediated tumor suppression in models of breast cancer
A biologic scaffold–associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy
Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ
DNA Methylation Markers for Breast Cancer Detection in the Developing World
Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3
Guidelines for the selection of functional assays to evaluate the hallmarks of cancer
HOXC10 Expression Supports the Development of Chemotherapy Resistance by Fine Tuning DNA Repair in Breast Cancer Cells
Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate
Multiplexed detection of serological cancer markers with plasmon-enhanced Raman spectro-immunoassay
Erratum to: Modeling precision treatment of breast cancer
Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis
Genetic and Phenotypic Diversity in Breast Tumor Metastases
Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast Cancer
Activation of diverse signalling pathways by oncogenic PIK3CA mutations
Modeling precision treatment of breast cancer
Molecular Pathways: Current Role and Future Directions of the Retinoic Acid Pathway in Cancer Prevention and Treatment
HMGA1: A Master Regulator of Tumor Progression in Triple-Negative Breast Cancer Cells
HOXB13 Mediates Tamoxifen Resistance and Invasiveness in Human Breast Cancer by Suppressing ERα and Inducing IL-6 Expression
Molecular Profiling of Human Mammary Gland Links Breast Cancer Risk to a p27+ Cell Population with Progenitor Characteristics
Myeloid Progenitor Cells in the Premetastatic Lung Promote Metastases by Inducing Mesenchymal to Epithelial Transition
Collagen I fiber density increases in lymph node positive breast cancers: pilot study
Somatic mutations in the notch, NF‐KB, PIK3CA, and hedgehog pathways in human breast cancers